Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome

被引：4
|
作者：
Lete, Inaki [1 ,2 ]
Martinez, Ainara [1 ]
Lasaga, Irene [1 ]
Centurion, Eva [1 ]
Vesga, Amaia [1 ]
机构：
[1] Araba Univ Hosp, Obstet & Gynaecol Clin Management Unit, Vitoria, Spain
[2] Araba Univ Hosp, Obstet & Gynaecol Clin Management Unit, Txagorritxu Campus, Vitoria 01009, Spain
来源：
GYNECOLOGICAL ENDOCRINOLOGY | 2024年 / 40卷 / 01期
关键词：
Polycystic ovary syndrome; inositol; MYO/DCI ratio; HUMAN THECAL CELLS; GROWTH-FACTOR-I; FOLLICULAR-FLUID; OOCYTE QUALITY; THERAPEUTIC APPROACH; ANDROGEN PRODUCTION; GENE-PRODUCTS; IGF-II; MYOINOSITOL; WOMEN;
D O I：
10.1080/09513590.2023.2301554
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this article, we present a narrative review on the use of inositol in the treatment of polycystic ovary syndrome (PCOS). Of the different inositols that exist, only myo-inositol (MYO) and D-chiro inositol (DCI) have been studied in the treatment of PCOS. The results of the studies show that there is insufficient or controversial evidence to recommend the use of DCI alone, while MYO alone shows positive results and, above all, the MYO/DCI combination is effective when used at a ratio of at least 40:1, but there is enough rationale to further study ratios such as 66:1 to 100:1 as other possible effective combinations.
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Results from the International Consensus Conference on Myo-inositol and D-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS
    Facchinetti, Fabio
    Bizzarri, Mariano
    Benvenga, Salvatore
    D'Anna, Rosario
    Lanzone, Antonio
    Soulage, Christophe
    Di Renzo, Gian Carlo
    Hod, Moshe
    Cavalli, Pietro
    Chiu, Tony T.
    Kamenov, Zdravko A.
    Bevilacqua, Arturo
    Carlomagno, Gianfranco
    Gerli, Sandro
    Oliva, Mario Montanino
    Devroey, Paul
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2015, 195 : 72 - 76
  • [42] A stereospecific myo-inositol D-chiro-inositol transporter in HepG2 liver cells - Identification with D-chiro-[3-H-3]inositol
    Ostlund, RE
    Seemayer, R
    Gupta, S
    Kimmel, R
    Ostlund, EL
    Sherman, WR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (17) : 10073 - 10078
  • [43] Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology - assisted reproduction technology
    Bevilacqua, Arturo
    Carlomagno, Gianfranco
    Gerli, Sandro
    Oliva, Mario Montanino
    Devroey, Paul
    Lanzone, Antonio
    Soulange, Christophe
    Facchinetti, Fabio
    Di Renzo, Gian Carlo
    Bizzarri, Mariano
    Hod, Moshe
    Cavalli, Pietro
    D'Anna, Rosario
    Benvenga, Salvatore
    Chiu, Tony T.
    Kamenov, Zdravko A.
    GYNECOLOGICAL ENDOCRINOLOGY, 2015, 31 (06) : 441 - 446
  • [44] Increased urinary excretion of myo-inositol and D-chiro-inositol in diabetes occurs independently of hyperglycaemia in the isolated perfused kidney
    Loomes, K. M.
    Choong, B.
    Phillips, A.
    Chang, H. -H.
    DIABETOLOGIA, 2011, 54 : S441 - S441
  • [45] The Role of Myo-Inositol in the regulation of female hormones and Polycystic Ovary Syndrome
    Martinez-Loria, Hazel Johanna
    Vargas-Zuniga, Lester Fabian
    Gonzalez-Vargas, Joshua Andrey
    Cordero-Robles, Kristel Mariana
    Urrea-Mayorga, Maria Jose
    TECNOLOGIA EN MARCHA, 2024, 37 (04): : 133 - 140
  • [46] Increased Circulating Levels of Myo-inositol in Girls with Polycystic Ovary Syndrome
    Bahadir, Nisan Ucer
    Guler, Eray Metin
    Kale, Ebru
    Aktas, Selman
    Cakir, Aydilek Dagdeviren
    Sutcu, Zumrut Kocabey
    Esen, Firuzan
    Beyaztas, Hakan
    Dastan, Ali Imran
    Ucar, Ahmet
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 375 - 376
  • [47] Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies
    Philippe Merviel
    Pandora James
    Sarah Bouée
    Mathilde Le Guillou
    Camille Rince
    Charlotte Nachtergaele
    Véronique Kerlan
    Reproductive Health, 18
  • [48] Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies
    Merviel, Philippe
    James, Pandora
    Bouee, Sarah
    Le Guillou, Mathilde
    Rince, Camille
    Nachtergaele, Charlotte
    Kerlan, Veronique
    REPRODUCTIVE HEALTH, 2021, 18 (01)
  • [49] Pregnancy Alters Urinary Excretion of Myo-Inositol and D-Chiro-Inositol.
    Murphy, Aisling
    Ma, Lina
    Shamshirsaz, Amir
    Ostlund, Richard E.
    Koos, Brian
    REPRODUCTIVE SCIENCES, 2013, 20 (S3) : 310A - 310A
  • [50] The Role of myo-inositol/D-chiro-inositol in a physiological ratio of 40: 1 in preventing the onset of gestational diabetes mellitus
    Farren, M.
    Daly, N.
    McKeating, A.
    Turner, M. J.
    Daly, S.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2016, 123 (13) : E3 - E3
12345